Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trialMehreen S. Datoo, Nsajigwa Misidai, Alassane Dicko et al.|The Lancet|2024Cited by 345
Predicting the likelihood and intensity of mosquito infection from sex specific Plasmodium falciparum gametocyte densityJohn Bradley, Teun Bousema, William J. Stone et al.|eLife|2018Cited by 143
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trialAlassane Dicko, Teun Bousema, Harouna M Soumaré et al.|The Lancet Infectious Diseases|2018Cited by 126
A Molecular Assay to Quantify Male and Female Plasmodium falciparum Gametocytes: Results From 2 Randomized Controlled Trials Using Primaquine for Gametocyte ClearanceWilliam J. Stone, Teun Bousema, Patrick Sawa et al.|The Journal of Infectious Diseases|2017Cited by 56
Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled TrialSusana Scott, Franco Pagnoni, Umberto D’Alessandro et al.|Clinical Infectious Diseases|2018Cited by 43